CMMB News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-19 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-07-08 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-06-02 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-05-14 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-05-06 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-04-28 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-03-20 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2026-03-19 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-11-21 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-08-22 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-08-14 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-07-25 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-07-01 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-05-27 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-05-15 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-04-15 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-03-27 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-03-20 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-03-03 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2025-02-19 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-11-18 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-11-14 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-10-11 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-08-21 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-07-25 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-06-12 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-05-09 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-05-08 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-05-03 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-03-07 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2024-01-03 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2023-11-09 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2023-08-14 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2023-08-08 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2023-07-03 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2023-06-16 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02. |
| 2023-06-05 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2023-05-11 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2023-02-21 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2023-02-21 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01,9.01. |
| 2023-01-11 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 7.01,9.01. |
| 2023-01-03 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01,9.01. |
| 2022-11-29 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K/A | Chemomab Therapeutics Ltd. filed Form 8-K/A covering items 9.01. |
| 2022-11-16 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01. |
| 2022-11-14 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2022-08-12 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2022-06-21 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 9.01. |
| 2022-06-08 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.07. |
| 2022-06-01 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02. |
| 2022-05-12 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2022-03-09 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2022-02-11 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.07. |
| 2021-12-16 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2021-12-03 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2021-11-12 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2021-11-12 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K/A | Chemomab Therapeutics Ltd. filed Form 8-K/A covering items 5.02,7.01,9.01. |
| 2021-11-10 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 7.01,9.01. |
| 2021-11-08 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2021-11-03 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 7.01,9.01. |
| 2021-10-26 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.07. |
| 2021-10-25 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 7.01,9.01. |
| 2021-09-02 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2021-08-13 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2021-07-22 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.07. |
| 2021-05-13 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.02,9.01. |
| 2021-04-14 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K/A | Chemomab Therapeutics Ltd. filed Form 8-K/A covering items 9.01. |
| 2021-04-05 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01,9.01. |
| 2021-03-19 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K/A | Chemomab Therapeutics Ltd. filed Form 8-K/A covering items 9.01. |
| 2021-03-17 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.07,9.01. |
| 2021-03-10 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01. |
| 2021-02-08 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01. |
| 2020-12-15 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2020-10-20 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02. |
| 2020-07-15 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02. |
| 2020-07-09 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,8.01. |
| 2020-05-21 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02. |
| 2020-05-06 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2020-04-24 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.07. |
| 2020-04-15 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 3.01. |
| 2020-03-16 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01. |
| 2020-02-10 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,8.01. |
| 2020-02-04 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 2.05,7.01,9.01. |
| 2020-01-31 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01. |
| 2020-01-10 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 8.01. |
| 2020-01-02 | Current report | SEC filing | Chemomab Therapeutics Ltd. filed Form 8-K | Chemomab Therapeutics Ltd. filed Form 8-K covering items 5.02,8.01. |
| 2019-11-21 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-11-15 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-11-12 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-10-28 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-09-23 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-08-13 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-08-06 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-07-08 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-06-18 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-05-28 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-05-22 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-03-14 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-03-12 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-02-14 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |
| 2019-02-12 | Foreign issuer report | SEC filing | Chemomab Therapeutics Ltd. filed Form 6-K | Chemomab Therapeutics Ltd. filed Form 6-K. |